Skip to main content
AMRN
NASDAQ Life Sciences

Amarin 第一季度收入增长 7% 至 4510 万美元，净亏损缩窄至 1050 万美元

feedReported by Wiseek News
Sentiment info
Positive
Importance info
8
Price
$13.96
Mkt Cap
$290.517M
52W Low
$9.44
52W High
$20.9
Market data snapshot near publication time

summarizeSummary

Amarin 公布了强劲的 2026 年第一季度业绩，净收入同比增长 7% 至 4510 万美元，GAAP 净亏损大幅缩窄至 1050 万美元。该公司还实现了连续第二个季度的正现金流，表明其财务状况有所改善。这些业绩建立在最近的 10-K 报告基础上，强调了全球重组和欧洲许可协议，表明战略举措的成功执行。积极的业绩主要由国际销售额增加和美国品牌 VASCEPA 处方的韧性驱动，同时营业费用大幅减少。交易者应注意持续的运营改进，并关注欧洲商业推广和商业模式转变对未来季度的影响的进一步更新。

在该公告发布时，AMRN的交易价格为$13.96，交易所为NASDAQ，所属行业为Life Sciences，市值约为$2.9亿。 52周交易区间为$9.44至$20.90。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Wiseek News。

show_chartPrice Chart

Share this article

Copied!

feed AMRN - Latest Insights

AMRN
Apr 29, 2026, 5:38 PM EDT
Source: Reuters
Importance Score:
9
Amarin's Vascepa Patent Future Hinges on Supreme Court Generic Drug Ruling
Sentiment: Neutral
View Wiseek Article
AMRN
Apr 29, 2026, 7:13 AM EDT
Source: Wiseek News
Importance Score:
8
Amarin's Q1 Revenue Climbs 7% to $45.1M, Narrows Net Loss to $10.5M
Sentiment: Positive
View Wiseek Article
AMRN
Apr 29, 2026, 7:06 AM EDT
Filing Type: 10-Q
Importance Score:
8
Amarin Reports Strong Q1 2026 Results with Positive Operating Cash Flow and Settles Antitrust Class Actions
Sentiment: Positive
View Wiseek Article
AMRN
Apr 29, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Amarin Reports Strong Q1 2026 Results with Revenue Growth and Positive Cash Flow
Sentiment: Positive
View Wiseek Article
AMRN
Apr 10, 2026, 5:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Amarin Seeks Shareholder Approval for Significant Dilution and to Override Prior Pre-emption Rights Rejection
Sentiment: Negative
View Wiseek Article
AMRN
Apr 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
ACC 2026 Sessions Emphasize Amarin's Icosapent Ethyl for Cardiovascular Risk Reduction
Sentiment: Positive
View Wiseek Article
AMRN
Mar 30, 2026, 5:57 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Shareholders to Vote on Significant Share Issuance Authority and Equity Plan Expansion
Sentiment: Negative
View Wiseek Article
AMRN
Mar 02, 2026, 5:31 PM EST
Filing Type: 10-K
Importance Score:
8
Amarin Reports Significantly Reduced 2025 Net Loss and Positive Operating Cash Flow Amid Strategic Restructuring and Ongoing Legal Battles
Sentiment: Neutral
View Wiseek Article
AMRN
Feb 25, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
8
Amarin Reports Strong Q4 & Full Year 2025 Results, Achieves Positive Cash Flow Ahead of Schedule
Sentiment: Positive
View Wiseek Article
AMRN
Jan 08, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
9
Amarin Achieves Positive Q4 2025 Cash Flow Ahead of Schedule, Reports Strong $303M Cash Balance and Sustained VASCEPA Leadership
Sentiment: Positive
View Wiseek Article